In a newly diagnosed Ulcerative Colitis patient, what is the current colonoscopy screening recommendation?

Prepare for the PANCE Board Exam with our comprehensive quiz. Study with detailed questions and explanations. Sharpen your skills and boost your confidence for exam day!

Multiple Choice

In a newly diagnosed Ulcerative Colitis patient, what is the current colonoscopy screening recommendation?

Explanation:
Chronic inflammation from ulcerative colitis raises colorectal cancer risk as disease duration and extent increase, so surveillance colonoscopy is used to catch dysplasia early. The current guideline is to start colonoscopic cancer surveillance about 8–10 years after diagnosis (reflecting years of disease), and to repeat every 1–2 years if the disease is extensive and no dysplasia has been found. This approach targets dysplasia before it progresses to cancer and allows timely intervention, since the risk rises with time and extent. A baseline evaluation at diagnosis to map disease extent and obtain biopsies is often done, but it doesn’t define the long-term surveillance interval. Starting screening at a fixed age like 50 or 40 or performing it immediately after diagnosis would miss the duration-based risk pattern in ulcerative colitis.

Chronic inflammation from ulcerative colitis raises colorectal cancer risk as disease duration and extent increase, so surveillance colonoscopy is used to catch dysplasia early. The current guideline is to start colonoscopic cancer surveillance about 8–10 years after diagnosis (reflecting years of disease), and to repeat every 1–2 years if the disease is extensive and no dysplasia has been found. This approach targets dysplasia before it progresses to cancer and allows timely intervention, since the risk rises with time and extent. A baseline evaluation at diagnosis to map disease extent and obtain biopsies is often done, but it doesn’t define the long-term surveillance interval. Starting screening at a fixed age like 50 or 40 or performing it immediately after diagnosis would miss the duration-based risk pattern in ulcerative colitis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy